ELVN

Enliven Therapeutics, Inc.

CIK 0001672619 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations

$52.18

↑ 1.38 (2.72%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals

Key stats

Market Cap

$3.18B

P/E Ratio

-32.17

EPS

-1.83

Dividend Yield

Not covered

52W Position

99%

Beta

0.98

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

7.01

P/S

Not covered

EV/Revenue

Not covered

ROE

-21.8%

Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 99%

$14.79$52.39

Latest Financials

2025-12-31 FY

Revenue

–

Net Income

-$103.69M

Total Assets

$476.17M

Free Cash Flow

–

ELVN

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

ELVN

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news